Sala A

II Sessione (Fabrizio Tiratterra)

16:00-16:10
Risk of pneumonia and exacerbations with single inhaler extrafinetriple therapy compared to indacaterol/glycopyrronium: Post-hoc Analysis of the TRIBUTE Study
Leonardo M. Fabbri
16:10-16:20
Seven-year efficacy and safety of azathioprine treatment in the maintainance of steroid-free remission in inflammatory bowel disease patients
Claudio Cassieri
16:20-16:30
Two-year outcomes of dabigatran etexilate treatment in patients with co-morbid heart failure and atrial ļ¬brillation: the GLORIA-AF registry
Raffaella Benedetti
16:30-16:40
Discussione sui temi trattati
16:30-16:40
The Annurca apple polyphenols is effective on intermittent claudication in patients with peripheral artery disease
Maria D'Avino
16:40-16:45
Take home message
Roberto Frediani